KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Hims & Hers Health (HIMS) Shares Outstanding (2019 - 2025)

Hims & Hers Health (HIMS) has disclosed Shares Outstanding for 7 consecutive years, with $227.2 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 2612.53% to $227.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $227.2 million through Dec 2025, up 2612.53% year-over-year, with the annual reading at $227.2 million for FY2025, 2612.53% up from the prior year.
  • Shares Outstanding hit $227.2 million in Q4 2025 for Hims & Hers Health, up from $8.4 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $227.2 million in Q4 2025 to a low of $8.4 million in Q3 2025.
  • Historically, Shares Outstanding has averaged $201.1 million across 5 years, with a median of $210.1 million in 2023.
  • Biggest five-year swings in Shares Outstanding: tumbled 96.08% in 2024 and later surged 2612.53% in 2025.
  • Year by year, Shares Outstanding stood at $204.8 million in 2021, then increased by 1.78% to $208.4 million in 2022, then increased by 2.42% to $213.5 million in 2023, then plummeted by 96.08% to $8.4 million in 2024, then soared by 2612.53% to $227.2 million in 2025.
  • Business Quant data shows Shares Outstanding for HIMS at $227.2 million in Q4 2025, $227.5 million in Q3 2025, and $225.8 million in Q2 2025.